Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer

Authors :: Hirotsugu Kenmotsu
Tateaki Naito
Takashi Nakajima
Haruyasu Murakami
Shota Omori
Haruki Kobayashi
Kazuhisa Nakashima
Toshiaki Takahashi
Akira Ono
Masahiro Endo
Kazushige Wakuda
Source :: Japanese Journal of Clinical Oncology. 48:822-826
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.
Abstract: Background The treatment efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer is unclear. Methods We defined refractory relapse as treatment-free interval

Tools